The impact of IMM-101 on Dendritic cells (II)

Further data from an ongoing collaboration between the laboratory of Prof. Andrew MacDonald at Manchester Collaborative Centre for Inflammation Research (University of Manchester, Manchester, UK) and Immodulon Therapeutics on the effects of IMM-101 (a heat-killed whole cell preparation of Mycobacterium obuense NCTC13365) on dendritic cells, key players in both innate and adaptive immunity, were presented at the 2016 Biennial Congress of European Association of Cancer Research (EACR).


Full title: The impact of Mycobacterium obuense (NCTC13365) on innate and adaptive immunity

Poster presented at the Biennial Congress of the EACR, held in Manchester (UK)
Date: 9-12 July 2016
Author[s]: James Crooks, Sheila Brown, Cecilia Forss, Alex Phythian-Adams, Peter Cook, Laura Rosa Brunet and Andrew MacDonald

Journal: European Journal of Cancer

DOI: http://dx.doi.org/10.1016/S0959-8049(16)61251-0